ENTITY
NATCO Pharma

NATCO Pharma (NTCPH IN)

49
Analysis
Health Care • India
NATCO Pharma is a research and development-driven pharmaceutical company focused on complex generics, niche products, and active pharmaceutical ingredients (APIs). It specializes in various therapeutic areas including oncology, cardiology, and diabetology, and also has a Crop Health Sciences division for agrochemical products. The company is headquartered in Hyderabad, India, and was founded in 1981.
more
•12 Jan 2017 14:54

IPO Pipeline to Remain Strong as PE Funds, Quasi-Govt Promoters Aim for Portfolio Exits

Primary issuances are expected to remain strong in 2017 following a five-year high in funds raised in 2016 (Rs 220bn) even as Fed rate expectations...

Logo
1.4k Views
Share
•08 Dec 2016 08:24

MediSetter Interview:Ā Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.2k Views
Share
•22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Logo
5.1k Views
Share
•01 Mar 2015 23:26

India's Budgets: 2006-2015. Key Charts, and Key questions

In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective: Ā 2014 Actual...

Share
•10 Oct 2025 14:45

Canara HSBC Life Insurance IPO - Improving AUM but Dependent on Bancassurance Channels

Canara HSBC Life Insurance is looking to raise US$284m from its upcoming India IPO, which is an entire secondary share sale. In this note, we talk...

Logo
654 Views
Share
x